Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Clovis Oncology Inc CLVSQ

Clovis Oncology, Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe and additional international markets. Its segments include U.S. and ex-U.S. Its product, Rubraca, is an oral small molecule inhibitor of poly ADP-ribose polymerase (PARP) marketed in the United States for two indications... see more

Bullboard (PINL:CLVSQ)

View:
Post by aabrahadabraaon Feb 09, 2021 9:45pm

no brainer.

Just scooped up 560!!!! 
Post by Chartsmart99on Jan 27, 2021 1:03pm

Very good pick

I bought it at $6. And I m so proud of my decision for holding it.
Post by schoolofrockon Sep 04, 2020 9:46am

Targeted Therapy - Opportunity to Ditch Chemo?

PARP inhibitors - Clovis, Astra Zeneca, Tesaro, more at:   https://www.channelchek.com/news-channel/An_Opportunity_to_Ditch_Chemotherapy_and_Still_Treat_Cancer  
Post by coolfooldumbguyon Jan 17, 2020 10:49am

it's a buy today for me

got it at $9.59 per share,so glta.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities